Evidence map›Paper›PMID 34617510›Full record

ArticleeLife2021

Modulation of fracture healing by the transient accumulation of senescent cells.

Dominik Saul, David G Monroe, Jennifer L Rowsey, Robyn Laura Kosinsky, Stephanie J Vos, Madison L Doolittle, Joshua N Farr, Sundeep Khosla

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Youthfulness of marrow AdipoqBone research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Musculoskeletal imaging of senescence.Skeletal radiology · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dominik SaulDivision of Endocrinology, Mayo Clinic, Rochester, United States.ORCID 0000-0002-0673-3710
David G MonroeDivision of Endocrinology, Mayo Clinic, Rochester, United States.
Jennifer L RowseyDivision of Endocrinology, Mayo Clinic, Rochester, United States.
Robyn Laura KosinskyDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States.
Stephanie J VosDivision of Endocrinology, Mayo Clinic, Rochester, United States.
Madison L DoolittleDivision of Endocrinology, Mayo Clinic, Rochester, United States.
Joshua N FarrDivision of Endocrinology, Mayo Clinic, Rochester, United States.ORCID 0000-0002-3179-6414
Sundeep KhoslaDivision of Endocrinology, Mayo Clinic, Rochester, United States.ORCID 0000-0002-2936-4372
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla, Nathan K LeBrasseur · 2019 to 2026
$28.7M
Targeting Cellular Senescence and RAGE in Type 2 DiabetesR01DK128552 · NIDDK · UNIVERSITY OF ARIZONA · PI FARR, JOSHUA NICHOLAS · 2021 to 2025
$2.0M
The Role of miR-219a-5p in Bone MetabolismR01AG063707 · NIA · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 2020 to 2024
$1.5M
Postdoctoral Training Program for Research on AgingT32AG049672 · NIA · MAYO CLINIC ROCHESTER · PI PASSOS, JOAO · 2016 to 2022
$1.3M
Targeting cellular senescence with senolytics to improve skeletal health in older humansR21AG065868 · NIA · MAYO CLINIC ROCHESTER · PI FARR, JOSHUA NICHOLAS, KHOSLA, SUNDEEP · 2020 to 2021
$419k
NIA NIH HHS L30 AG074419NIA NIH HHS P01 AG062413NIA NIH HHS R01 AG063707NIA NIH HHS R21 AG065868NIA NIH HHS T32 AG049672NIDDK NIH HHS R01 DK128552
6 · The paper itself

Abstract

Senescent cells have detrimental effects across tissues with aging but may have beneficial effects on tissue repair, specifically on skin wound healing. However, the potential role of senescent cells in fracture healing has not been defined. Here, we performed an in silico analysis of public mRNAseq data and found that senescence and senescence-associated secretory phenotype (SASP) markers increased during fracture healing. We next directly established that the expression of senescence biomarkers increased markedly during murine fracture healing. We also identified cells in the fracture callus that displayed hallmarks of senescence, including distension of satellite heterochromatin and telomeric DNA damage; the specific identity of these cells, however, requires further characterization. Then, using a genetic mouse model (

Indexed as

Cellular SenescenceFracture HealingAnimalsBiomarkersDNA DamageFemaleHumansMaleMiceModels, AnimalBiomarkersbonecallusfracturemedicinemouse

Identifiers

PMID34617510
PMCPMC8526061
OpenAlexW3201873895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.